Drug General Information (ID: DDIPI072OX)
  Drug Name Olanzapine Drug Info Halothane Drug Info
  Drug Type Small molecule Small molecule
  Therapeutic Class Antipsychotic Agents Anesthetics
  Structure

 Mechanism of Olanzapine-Halothane Interaction (Severity Level: Moderate)
     Increased risk of prolong QT interval Click to Show/Hide Mechanism Graph
Could Not Find 2D Structure
      Drug Name Olanzapine Halothane
      Mechanism Prolong QT interval Prolong QT interval
      Key Mechanism Factor 1
Factor Name QT interval
Factor Description Long QT syndrome is a heart signaling disorder that can cause a fast, chaotic heartbeat (arrhythmia). Many people may not exhibit symptoms, and usually the condition is detected during routine medical tests. In others, the most common symptoms include: sudden fainting, palpitations, dizziness, seizures, sudden death.
      Mechanism Description
  • Increased risk of prolong QT interval by the combination of Olanzapine and Halothane 

Recommended Action
      Management Some authorities recommend caution when olanzapine is used with drugs that are known to cause QT prolongation.

References
1 Cerner Multum, Inc. "Australian Product Information.".
2 Cerner Multum, Inc. "UK Summary of Product Characteristics.".
3 Product Information. Zyprexa (olanzapine). Lilly, Eli and Company, Indianapolis, IN.